The Impact of Interpretation Bias Modification Training on Anger and Reactive Aggression

March 23, 2020 updated by: Monique Tremblay, Ryerson University

An Investigation of the Short-term Impact of Interpretation Bias Modification Training on Anger Symptoms, Reactive Aggression, and Attentional Biases Toward Anger-related Stimuli

Difficulties with anger control are reported in a number of psychological conditions and are associated with social problems, such as dating violence and workplace violence. High trait anger is a personality construct characterized by elevations in the frequency, duration, and intensity of anger episodes. However, the cognitive processes contributing to high trait anger are still poorly understood. This study will examine the effectiveness of a computer-based cognitive bias modification (CBM) program designed to target hostile interpretations associated with high trait anger.

Study Overview

Detailed Description

High trait anger is a personality construct characterized by elevations in the frequency, duration, and intensity of anger episodes. According to the Integrative Cognitive Model (ICM) of anger, three cognitive processes jointly contribute to an individual's level of trait anger and reactive aggression: hostile attributions, ruminative attention, and effortful control processes. Specifically, individuals high in trait anger are more prone to interpret ambiguous situations as hostile; are more likely to ruminate about anger-related events; and have a more limited capacity to employ control processes when they become angry.

One means of evaluating unconscious biases that has become increasingly popular is cognitive bias modification (CBM). CBM programs are computerized training paradigms, which aim to train more adaptive cognitive biases by repeatedly exposing participants to an experimental contingency between an emotional stimulus and a response.Previous researchers have begun to investigate the impact of CBMs targeting cognitive control and hostile attribution bias in relation to anger. However, these studies have been conducted exclusively in samples reporting low trait anger.

This study will examine the effectiveness of a short-term interpretation bias modification program (CBM-I) on hostile attribution biases and reactive aggression in a sample of undergraduate students eporting high trait anger.

Study Type

Interventional

Enrollment (Actual)

47

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ontario
      • Toronto, Ontario, Canada, M5B 2K3
        • Ryerson University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

1. Students scoring 22 or higher on the Trait Anger Scale.

Exclusion Criteria:

  1. Reports currently receiving psychological treatment or counseling for anger.
  2. Reports changes in psychiatric medication within the last month.
  3. Endorsement of current psychosis or bipolar disorder symptoms.
  4. Indicates poor English language proficiency.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Interpretation bias modification program
Participants in this arm will complete a computer-based training program two times in the lab. Participants will complete the first training session in the lab during their initial visit and they will return to the lab one week later to complete the second session.
A computer based interpretation bias modification program that aims to reinforce neutral interpretations of ambiguous social situations.
Sham Comparator: Control training program
Participants in this arm will complete a sham training program two times in the lab. The program will look similar in length and design to the experimental training program, but the content of the program will remain affectively neutral. As in the experimental condition, participants will complete the first training session in the lab during their initial visit and they will return to the lab one week later to complete the second session.
A sham training program that is similar in design and delivery to the experimental training condition.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
State-Trait Anger Expression Inventory 2nd Edition
Time Frame: Administered two times over the course of one week. Changes will be examined from visit 1 (before CBM training program) to visit 2 (after CBM training program).
A self-report measure of the experience of anger.
Administered two times over the course of one week. Changes will be examined from visit 1 (before CBM training program) to visit 2 (after CBM training program).
Interpretation Bias Assessment
Time Frame: Administered two times over the course of one week. Changes will be examined from visit 1 (before CBM training program) to visit 2 (after CBM training program).
A computer-based measure of hostile interpretation bias involving ambiguous social scenarios.
Administered two times over the course of one week. Changes will be examined from visit 1 (before CBM training program) to visit 2 (after CBM training program).

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Anger Rumination Scale
Time Frame: Administered two times over the course of one week. Changes will be examined from visit 1 (before CBM training program) to visit 2 (after CBM training program).
A self-report measure of the degree to individuals focus on experiences with anger. The scale is comprised of four subscales, angry after thoughts (e.g., "Whenever I experience anger, I keep thinking about it for a while"), angry memories (e.g., "I re-enact the anger episode in my mind after it has happened"), understanding causes (e.g., "When someone provokes me, I keep wondering why this should have happened to me"), and thoughts of revenge (e.g. "I have difficulty forgiving people who have hurt me."). Participants will be asked to read each item and rate it in terms of how well it reflects their experience on a 4-point scale from 1 ("almost never") to 4 ("almost always"). Totals for each sub scale will be summed to produce a total score (range: 19-76), with higher scores indicating a greater propensity for rumination.
Administered two times over the course of one week. Changes will be examined from visit 1 (before CBM training program) to visit 2 (after CBM training program).
Social Information Processing-Attribution and Emotional Response Questionnaire
Time Frame: Administered two times over the course of one week. Changes will be examined from visit 1 (before CBM training program) to visit 2 (after CBM training program).
A self-report measure of evaluate social information processing biases associated with hostile attribution bias.
Administered two times over the course of one week. Changes will be examined from visit 1 (before CBM training program) to visit 2 (after CBM training program).
Word Sentence Association Paradigm-Hostility
Time Frame: Administered two times over the course of one week. Changes will be examined from visit 1 (before CBM training program) to visit 2 (after CBM training program).
A behavioural measure of hostile attribution biases involving hostile and non-hostile words.
Administered two times over the course of one week. Changes will be examined from visit 1 (before CBM training program) to visit 2 (after CBM training program).
Depression and Anxiety Stress Scale-21
Time Frame: Administered two times over the course of one week. Changes will be examined from visit 1 (before CBM training program) to visit 2 (after CBM training program).
A self-report measure of depression, anxiety, and stress symptoms. A self-report measure of depression, anxiety, and stress symptoms.Items are summed for each subscale to create subscale totals (i.e., depression, anxiety, and stress), with higher scores reflecting more severe emotional distress. Symptom score ranges include: normal (0-4), mild (5-6), moderate (7-10), severe (11-13), and extremely severe (14+).
Administered two times over the course of one week. Changes will be examined from visit 1 (before CBM training program) to visit 2 (after CBM training program).
Dot Probe
Time Frame: Administered two times over the course of one week. Changes will be examined from visit 1 (before CBM training program) to visit 2 (after CBM training program).
A behavioural measure of attentional bias towards angry faces.
Administered two times over the course of one week. Changes will be examined from visit 1 (before CBM training program) to visit 2 (after CBM training program).
Reactive-Proactive Aggression Questionnaire
Time Frame: Administered two times over the course of one week. Changes will be examined from visit 1 (before CBM training program) to visit 2 (after CBM training program).
A self-report measure of an individual's propensity for reactive aggression.
Administered two times over the course of one week. Changes will be examined from visit 1 (before CBM training program) to visit 2 (after CBM training program).
Taylor Aggression Paradigm
Time Frame: Administered one time over the course of one week. Participants will be exposed to the paradigm following the second training session.
A behavioural measure of reactive aggression.
Administered one time over the course of one week. Participants will be exposed to the paradigm following the second training session.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 12, 2019

Primary Completion (Actual)

March 13, 2020

Study Completion (Actual)

March 13, 2020

Study Registration Dates

First Submitted

September 22, 2018

First Submitted That Met QC Criteria

September 22, 2018

First Posted (Actual)

September 25, 2018

Study Record Updates

Last Update Posted (Actual)

March 24, 2020

Last Update Submitted That Met QC Criteria

March 23, 2020

Last Verified

March 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Anger Study 1

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

IPD Plan Description

The results of this study will be disseminated through conference presentations and journal publications. Anonymized aggregate participant data may be made available upon request to a publishing journal or individual research group. However, research groups interested in accessing anonymized data will be required to submit a proposal detailing their intended use of the data. Their qualifications will be reviewed based on their proposal and CVs. Individual research groups approved for access will be required to agree to not attempt to re-identify participants, not further distribute data, and not use the data for purposes other than specified in their original proposal. No individual data will be shared.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anger

Clinical Trials on Interpretation Bias Modification

Subscribe